Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid Leukemia
Clinical trial NCT02674763 · COMPLETED
Trial details
- NCT number
- NCT02674763
- Sponsor
- ImmunoGen, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-06-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.